Cannabinoids and the Treatment of Fibromyalgia
Cannabinoids offer a new frontier in the treatment of this debilitating disease.
Read moreCannabinoids offer a new frontier in the treatment of this debilitating disease.
Read moreSector specific funds outperform generalist contemporaries in key metrics according to published data.
Read moreGermany's diminished recreational framework is a positive for the therapeutic sector.
Read moreSynthetic biology is revolutionising the development of highly specific drugs, including those that target the endocannabinoid system.
Read moreA range of factors are coming together to the sector's benefit.
Read moreA number of multi billion dollar exits in the sector show the viability and potential of early stage medicinal cannabis…
Read moreJanuary 2023 has been a month of positives for the UK medicinal cannabis sector.
Read moreÓskare Capital correctly called a range of key sector events in 2022.
Read moreNorth American family offices are increasing private equity portfolio allocation in 2023.
Read moreMedical cannabis is providing doctors with a range of new treatments for chronic pain conditions.
Read moreGermany’s plan for legalisation changes its current supply model
Read moreCanverse and Oskare Capital discuss the UK Cannabis Investment Landscape
Read moreÓSKARE Fund I & Medical Cannabinoids
Read moreÓskare Capital is pleased to announce that Oliver Lamb will be joining as Co-Founder and Investment Manager in the investment…
Read moreThe good news for Europe’s Medical Cannabis industry is that, although not specifically named, the sector has touch points in…
Read moreMercia Asset Management has lost its investment director and university lead Nicola Broughton to a new $171m fund targeting the…
Read moreTHE Central Bank of Ireland has given the green light for an Irish domiciled investment fund that is seeking to…
Read moreIreland's first ever private equity medical cannabis fund has been established. The new venture has been set up by Crossroads…
Read moreOskare Capital lance Oskare Fund I, un fonds d'investissement qui va cibler des sociétés européennes développant des thérapies à base…
Read moreOctarine Bio IVS (“Octarine” or the “Company”), a synthetic biology company developing functionally superior cannabinoid and psilocybin derivatives using microbial…
Read more